From: Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC
Category | Subcategory | Results (%) |
---|---|---|
Age | ≥ 65 | 128 (62.1) |
 | < 65 | 78 (37.9) |
Gender | Male | 132 (64) |
 | Female | 74 (36) |
*Smoking status | Current | 78 (37.9) |
 | Former | 30 (14.6) |
 | Never | 12 (5.8) |
*Asbestos contact | Present | 17 (8) |
 | Absent | 49 (24) |
*COPD | Present | 43 (21) |
 | Absent | 5 (2) |
Histologic type | ADC | 100 (48.6) |
 | SCC | 86 (41.7) |
 | LCC | 12 (5.8) |
 | Other | 8 (3.9) |
ADC subtypes | Acinar predominant | 38 (18.4) |
 | Solid predominant | 25 (12.1) |
 | Papillary predominant | 22 (10.8) |
 | Micropapillary predominant | 10 (4.9) |
 | Invasive mucinous | 3 (1.4) |
 | Lepidic | 2 (1) |
Grade | Well | 5 (2.4) |
 | Moderate | 82 (39.8) |
 | Poor | 119 (57.8) |
Tumor size | T1 | 39 (18.9) |
 | T2 | 115 (55.8) |
 | T3 | 32 (15.5) |
 | T4 | 20 (9.8) |
Lymph node status | N0 | 99 (48.1) |
 | N1 | 49 (23.8) |
 | N2 | 43 (20.9) |
 | N3 | 15 (7.3) |
Stage | I | 68 (33) |
 | II | 57 (27.7) |
 | III | 73 (35.4) |
 | IV | 8 (3.9) |